Rationale and Design of the IMPROVE Trial: A Multicenter, Randomized, Controlled, Open-label, Blinded-endpoint Trial Assessing the Efficacy of Remote Ischemic Conditioning in Patients Undergoing Off-Pump Coronary Artery Bypass Grafting.
Yang YanChangying ZhaoJialan NiuPengyun YanJing LiDuolao WangGuoliang LiPublished in: Advances in therapy (2024)
NCT06141525 (ClinicalTrials.gov).
Keyphrases
- phase iii
- open label
- phase ii
- coronary artery bypass grafting
- study protocol
- double blind
- placebo controlled
- clinical trial
- patients undergoing
- coronary artery disease
- percutaneous coronary intervention
- phase ii study
- randomized controlled trial
- ischemia reperfusion injury
- squamous cell carcinoma
- cross sectional
- blood brain barrier